《北京市心血管内科质量控制和改进中心质控报告（2024年）》发布

Core Insights - The report indicates a significant improvement in the intervention treatment mortality rate for coronary heart disease in Beijing, dropping from 0.10% in 2023 to 0.01% in 2024, marking a historical low [1] - The median D2W time for acute ST-segment elevation myocardial infarction patients has decreased to 57 minutes in 2024, a reduction of 10 minutes from 2022, with 94.9% of cases achieving D2W time under 90 minutes, an increase of 10.8 percentage points from 2022 [1] Group 1 - The Beijing Cardiovascular Internal Medicine Quality Control and Improvement Center analyzed 536 adverse outcome cases in 2024, leading to optimized rescue processes across multiple hospitals, effectively reducing medical risks [2] - The collaborative rescue network in Beijing has been upgraded to cover 65 medical institutions, supported by 11 district-level quality control centers to enhance quality control at the district level [2] - The center aims to achieve homogenization and high-quality development in cardiovascular disease diagnosis and treatment, focusing on specialized training, quality monitoring, and the promotion of information technology tools [2]